Author: Wayne Winegarden

11 July, 2019 in Healthcare, Study, Uncategorized / 0 Comments

New Issue Brief: Increased Use of Biosimilars Could Bring Billions in Savings for Patients, Providers, Taxpayers

09 July, 2019 in Commentary, Healthcare / 0 Comments

Trump’s Healthcare Contradictions Threaten Beneficial Reforms

27 June, 2019 in Commentary, Healthcare / 0 Comments

Flawed WHO Study Could Jeopardize Patients’ Access to Cancer Medicines

02 June, 2019 in Business Economics, Commentary / 0 Comments

Are ESG Funds A Good, Long-Term Investment?

30 May, 2019 in Commentary, Healthcare / 0 Comments

Don’t Legislate Away Biopharmaceutical Innovation

29 May, 2019 in Blog, Healthcare / 0 Comments

“HELP-ing” to Make Health Care More Affordable

20 May, 2019 in Commentary, Healthcare / 0 Comments

Differentiating Health Care Costs from Health Care Value

16 May, 2019 in California, Commentary, Healthcare / 0 Comments

The Perils of Regulating Drugs by Sound Bite

06 May, 2019 in Commentary, Healthcare / 0 Comments

Pharmaceutical Rebates — Keeping The Right Score

30 April, 2019 in Commentary, Healthcare / 0 Comments

Price Controls by Another Name